Abstract: The present invention provides biologically active peptidomimetic macrocycles with improved properties relative to their corresponding polypeptides. The invention additionally provides methods of preparing and using such macrocycles, for example in therapeutic applications.
Type:
Application
Filed:
November 24, 2009
Publication date:
November 25, 2010
Applicant:
AILERON Therapeutics, Inc.
Inventors:
Huw M. Nash, David Allen Annis, Rosana Kapeller-Libermann, Tomi K. Sawyer, Noriyuki Kawahata
Abstract: The present invention provides biologically active crosslinked polypeptides with improved properties relative to their corresponding precursor polypeptides, having good cell penetration properties and reduced binding to human proteins. The invention additionally provides methods of identifying and making such improved polypeptides.
Type:
Application
Filed:
September 22, 2009
Publication date:
August 26, 2010
Applicant:
AILERON Therapeutics, Inc.
Inventors:
Huw M. Nash, David Allen Annis, Rosana Kapeller-Llbermann, Tomi K. Sawyer
Abstract: The present invention relates to purified peptidomimetic macrocycles. The invention additionally provides methods of preparing and using such macrocycles, for example in therapeutic applications.
Type:
Application
Filed:
September 22, 2009
Publication date:
August 19, 2010
Applicant:
AILERON Therapeutics, Inc.
Inventors:
Huw M. Nash, Matthew Iadanza, Christopher Leitheiser, Noriyuki Kawahata
Abstract: The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Type:
Application
Filed:
January 19, 2010
Publication date:
July 22, 2010
Applicant:
AILERON Therapeutics, Inc., a Delaware Corporation
Abstract: The present invention provides biologically active peptidomimetic macrocycles with improved properties relative to their corresponding polypeptides. The invention additionally provides methods of preparing and using such macrocycles, for example in therapeutic applications.
Type:
Application
Filed:
April 8, 2009
Publication date:
December 31, 2009
Applicant:
AILERON THERAPEUTICS, INC.
Inventors:
Huw M. Nash, Rosana Kapeller-Libermann, Tomi K. Sawyer, Noriyuki Kawahata, Vincent Guerlavais, Matthew Iadanza
Abstract: The present invention provides biologically active peptidomimetic macrocycles for the treatment of cell proliferative disorders such as cancer and immunoproliferative disease.
Type:
Application
Filed:
February 9, 2009
Publication date:
November 5, 2009
Applicant:
AILERON Therapeutics, Inc.
Inventors:
Huw M. Nash, David Allen Annis, Rosana Kapeller-Libermann, Tomi K. Sawyer, Noriyuki Kawahata, Jiawen Han
Abstract: The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Type:
Application
Filed:
June 16, 2008
Publication date:
April 2, 2009
Applicant:
AILERON Therapeutics, Inc., a Delaware Corporation
Abstract: The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Abstract: The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Type:
Application
Filed:
February 25, 2008
Publication date:
October 23, 2008
Applicant:
Aileron Therapeutics, Inc., A Delaware Corporation